Novonesis is the name

Danish enzymes and ingredients firms Novozymes and Chr. Hansen have announced that their post-merger name will be Novonesis. This is derived from the Latin word for ‘new’ that is already in Novozymes’ name and the Green for ‘origin’ or ‘beginning’, to acknowledge the role Ancient Greek thinkers played in the development of science.

The merger approval process is progressing as planned, with closing expected to take place in Q1 2024 following regulatory approval. The new name will be used and gradually implemented once the proposed combination is completed, with the two firms operating separately until that point.

Novonesis will have a global network of 23 manufacturing sites and nearly 40 R&D and application centres, with around 10,000 employees. It is committed to carbon neutrality by 2050, a 75% reduction in Scope 1 and 2 emissions from its own operations by 2030, and a 35% reduction in scope 3 emissions from the full supply chain by 2030.